Search Market Research Report
Obesity Intervention Devices Market Size, Share Global Analysis Report, 2023 – 2030
Obesity Intervention Devices Market Size, Share, Growth Analysis Report By Devices (Gastric Stimulation System, Gastric Balloon, Gastric Bands, And Others), By End Users (Hospitals And Clinics), And By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2023 – 2030
Industry Insights
[206+ Pages Report] According to Facts and Factors, the global obesity intervention devices market size was valued at USD 251.37 million in 2022 and is predicted to surpass USD 396.41 million by the end of 2023. The obesity intervention devices industry is expected to grow by a CAGR of 5.92%.
Market Overview
Obesity intervention devices refer to the medical tools manufactured to help in weight loss or management procedures among people facing obesity issues. These devices lower the health risks associated with the medical intervention procedures to help people achieve the required weight loss.
Key Insights
- As per the analysis shared by our research analyst, the global obesity intervention devices market size is estimated to grow annually at a CAGR of around 5.92%. over the forecast period (2023-2030).
- In terms of revenue, the global obesity intervention devices market size was valued at around USD 251.37 million in 2022 and is projected to reach USD 396.41 million by 2030.
- Rising prevalence of obesity is driving the growth of the global obesity intervention devices market.
- Based on the devices, the gastric band segment is growing at a high rate and is projected to dominate the global market.
- Based on the end users, the hospital segment is projected to swipe the largest market share.
- Based on region, North America is expected to dominate the global market during the forecast period.
Growth Drivers
- Rising prevalence of obesity is likely to drive the growth of the global market.
The high prevalence of obesity is a major health concern globally, which is driving the demand for different intervention procedures to treat obesity-associated health problems. Moreover, the increasing awareness and education among people regarding the side effects of obesity has significantly led them to opt for effective and less invasive obesity intervention procedures, which is likely to positively impact the growth of the global obesity intervention devices market in the forthcoming years.
Also, this supportive regulatory landscape globally is more likely to contribute towards the high growth rate of the industry metrics. Governments are showing clear guidelines and supportive regulations to encourage innovation and investment in the industry. The increasing disposable income of people is further fostering a habit of investing among people in healthcare care and wellness management aspects.
For instance, Spatz FGIA Inc. got the approval for Spatz3 Gastric Balloon by the FDA in October 2021. It is said to be the fifth gastric balloon that got approval by the FDA. Also, it is the first adjustable gastric balloon system to help people in their weight loss journey.
Restraints
- Lack of insurance coverage is likely to hamper the growth of the global market.
The presence of inadequate insurance coverage for obesity-associated surgeries and devices is likely to restrict patients from adopting the high pocket expenses. Also, the lack of reimbursement policies limits the adoption, particularly in less developing or underserved areas.
Opportunities
- Advancements in technology are likely to foster growth opportunities in the global market.
The ongoing technological innovation led to the development of less effective obesity intervention devices, which is likely to widen the scope of the obesity intervention devices industry. The increasing public health initiatives and government campaigns further lead to the high adoption of obesity intervention devices.
Furthermore, industry is highly affected by socioeconomic technology and regulatory factors, which led to an increase in the research and development activity of the innovation of advanced medical devices. Therefore, such a landscape is anticipated to contribute towards the market's growth. For instance, GI Dynamics Inc. came up with the EndoBarrier product in January 2022. It helps people diagnose Type 2 diabetes and obesity.
Challenges
- Technological limitations are a big challenge in the global market.
Technological limitations like limited effectiveness, compatibility issues, and a few others affect the adoption of obesity intervention procedures, which is a big challenge in the obesity intervention devices market. Also, these invasive procedures are a little complex, which deters certain patients who prefer simpler alternatives for obesity management. Therefore, such a landscape is likely to hinder the growth of the global market in the forthcoming years.
Segmentation Analysis
The global obesity intervention devices market can be segmented into devices, end-users, and regions.
By device, the market can be segmented into gastric stimulation system, gastric balloon, gastric bands, and others. The gastric band segment is expected to observe notable growth in the obesity intervention devices industry in the forthcoming years.
Gastric bands refer to the medical devices that help in bariatric surgery for weight loss. These devices are wrapped around the upper part of the stomach to help create a smaller stomach pouch to reduce food intake and satiety in human beings.
Also, the improvement in technology led to the innovation of more effective and safer devices, which reduce the complications in the patient outcome and thereby improve the success rates. Global obesity issue continues to be a major health concern, which is driving more demand for obesity management interventions like bariatric surgeries that involve the usage of gastric bands.
Gastric band surgery is a minimally basic procedure that is more convenient as compared to other available options like sleeve gastrectomy or gastric bypass, and therefore, it attracts a larger customer base.
By end-users, the market can be segmented into hospitals and clinics. The hospital segment is likely to dominate the global obesity intervention devices market with a high CAGR during the predicted period. Hospital is viewed as a primary point for the management, treatment, and diagnosis of various health-related issues like obesity and others.
Moreover, these are the points that undertake the obesity intervention procedures, and therefore, the segment is expected to see a huge development in the forthcoming years. Hospitals generally dedicate specialized departments, particularly for bariatric surgery and obesity management, thereby making the centers a preferred choice for patients looking forward to obesity treatment.
Also, hospitals hold the necessary infrastructure, qualified healthcare professionals, and advanced medical equipment to carry out bariatric surgeries. Another major factor propelling the growth of the segment is the higher trust level of people in hospitals in terms of expertise, medical care, and infrastructure required for treating conditions like obesity.
Moreover, hospitals are under restricted regulatory compliance. Therefore, the centers adhere to the government's protocol for the safety and success of the surgical intervention, which further ensures the patient's confidence in the hospital.
Report Scope
Report Attribute |
Details |
Market Size in 2022 |
USD 251.37 Million |
Projected Market Size in 2030 |
USD 396.41 Million |
CAGR Growth Rate |
5.92% CAGR |
Base Year |
2022 |
Forecast Years |
2023-2030 |
Key Market Players |
Abbvie Inc., Boston Scientific, GI Dynamics Inc., Endalis Laboratoire, Allurion Technologies Inc., Spatz FGIA Inc., Johnson & Johnson, A.M.I. GmbH, BAROnova Inc., Cousin Surgery, ReShape Lifesciences Inc., Medtronic plc, and Others. |
Key Segment |
By Devices, By End Users, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
- North America to dominate the global market.
North America accounts for the largest share of the global obesity intervention devices market in the forthcoming years because of the high prevalence of obesity incidences in the region. The United States is at the forefront of the obesity epidemic, with a larger portion of the population being affected by obesity-associated health problems.
However, such a high incidence of obesity has significantly increased the demand for obesity intervention devices and treatment. The region is witnessing advancements in the healthcare infrastructure and technological capabilities, which is giving it a competitive edge in the obesity intervention devices. These developments led to the introduction of cutting-edge medical devices and interventions for obesity management.
Moreover, the technological advancements in medical devices and the advent of minimally invasive surgical techniques are further expected to positively impact the growth trajectory of the regional market in the coming years. Also, the growing focus of people on the health and wellness aspects is also likely to support the growth of the regional market.
People are witnessing the long-term health implications of obesity, which is driving them to focus on weight management and look forward to various obesity intervention devices and procedures. The easy availability of insurance coverage and reimbursement policies will contribute heavily towards the growing demand for obesity intervention devices in the market.
Asia Pacific is expected to see huge developments in the forthcoming years due to the changing dynamics of the industry in the region. The region is witnessing a significant rise in obesity cases due to the increasing organization, industrialization, sedentary lifestyle and poor dietary habits. The high urbanization and industrialization rate, along with the high influence of Western culture on Asian nations has significantly led to a fast-paced, hectic lifestyle, which leads to the consumption of junk foods and on-the-go snacks.
Also, the physical activity patterns of the people have significantly changed along with the consumption of energy dense foods. Growth in economic standards also contributes towards the high obesity rate in the region. However, the increasing disposable income of people is driving them to work in healthcare and wellness aspects, which is likely to further positively impact the growth trajectory of the regional market.
For instance, Allurion Technologies, a US-based company, revealed the Allurion swallowable capsule in September 2022 to treat obesity in India. The product got approval through the Central Drugs Standard Control Organization (CDSCO).
Competitive Analysis
The key players in the global obesity intervention devices market include:
- Abbvie Inc.
- Boston Scientific
- GI Dynamics Inc.
- Endalis Laboratoire
- Allurion Technologies Inc.
- Spatz FGIA Inc.
- Johnson & Johnson
- A.M.I. GmbH
- BAROnova Inc.
- Cousin Surgery
- ReShape Lifesciences Inc.
- Medtronic plc
For instance, Boston Scientific is said to have successfully acquired Apollo Endosurgery in April 2023. The acquired company was involved in designing, developing, and commercializing the less invasive medical devices.
The global obesity intervention devices market is segmented as follows:
By Devices Segment Analysis
- Gastric Stimulation System
- Gastric Balloon
- Gastric Bands
- Others
By End Users Segment Analysis
- Hospitals
- Clinics
By Regional Segment Analysis
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Abbvie Inc.
- Boston Scientific
- GI Dynamics Inc.
- Endalis Laboratoire
- Allurion Technologies Inc.
- Spatz FGIA Inc.
- Johnson & Johnson
- A.M.I. GmbH
- BAROnova Inc.
- Cousin Surgery
- ReShape Lifesciences Inc.
- Medtronic plc
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors